The U.K. drugmaker reported net profit of $3.12 billion for the third quarter, up from $2.535 billion for the same period last year.
Source link
AstraZeneca Posts Revenue, Profit Growth on Strong Cancer-Drug Sales
Date:
Date:
The U.K. drugmaker reported net profit of $3.12 billion for the third quarter, up from $2.535 billion for the same period last year.
Source link